文献速递垂体与肾上腺疾病

诊断原发性醛固酮增多症是否必须停用RAAS修饰药物?

Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
PubMed 文献 · J Clin Endocrinol Metab · 2026-09-12

本文辩论诊断原发性醛固酮增多症时是否需停用作用于肾素-血管紧张素-醛固酮系统(RAAS)的降压药。正方强调准确诊断以实现靶向治疗,反方强调常规调整用药的可行性、安全性和成本。现有数据有限,前瞻性结局研究有望定义最佳策略。

要点

  • RAAS修饰药物影响醛固酮和肾素测量及醛固酮-肾素比值。
  • 指南推荐比值阈值诊断原醛症,停药以减少假阳性/假阴性。
  • 需前瞻性结局研究平衡诊断准确性与用药调整的风险。

核心结论

  • 停用RAAS修饰药物对原醛症诊断的必要性存在争议,现有证据有限。

研究设计与样本

  • 辩论类文章,对比正方与反方观点,未报告系统检索或样本量。

主要发现

  • 正方强调准确诊断以实现最佳靶向治疗。
  • 反方强调常规调整用药的可行性、安全性和成本。
  • 评估获益风险比的数据存在显著局限性。

临床怎么用

  • 临床需权衡诊断准确性 vs 停药可行性、安全性和成本。
  • 可关注新型检测和治疗的前瞻性结局研究以优化策略。

局限性

  • 评估诊断方法获益风险比的数据存在显著局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Several classes of antihypertensive drugs which act on the renin-angiotensin-aldosterone-system (RAAS) change the measurements in blood of aldosterone or renin, and hence the derived aldosterone-renin-ratio. Since guideline-recommended thresholds of this ratio are used for diagnosing primary aldosteronism, it has been common practice to withdraw potentially interfering drugs several weeks prior to diagnostic tests, in order to reduce the risk of false-positive and false-negative results. This debate highlights two opposing views on the necessity for such withdrawal. The Pro-side of the debate emphasizes the importance of an accurate diagnosis to achieve optimal targeted treatment results. The Con-side accentuates the importance of feasibility, safety and costs of routine adjustment of medication. The data available to evaluate the balance of benefit versus risk of these diagnostic approaches have considerable limitations. Prospective outcome studies of newer tests and treatments present an opportunity to define the optimal strategy for maximizing accurate diagnoses of primary aldosteronism.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Teo AED, Pamporaki C, Lenders JWM, et al. Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism? J Clin Endocrinol Metab. 2026. PMID: 42728832. doi:10.1210/clinem/dgag375

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。